JPM15: Medtronic Eyes $5bn-plus Opportunity In Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
Omar Ishrak, chairman and CEO of medtech giant Medtronic, believes he can boost his company’s annual revenues by $5 billion by selling existing products at existing prices to those people who can afford them in emerging markets. However, the strategy is not as straight forward as it first sounds.